The findings of Inozume et al. (50) and Ahmadzadeh et al. (51), that tumor-responsive T cells are enriched among CD8+PD1+ lymphocytes from fresh melanoma specimens, provide direct support for this notion. The gene discussed is CD8A; the disease is neoplasm.